v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities    
Net Loss $ (13,282) $ (24,275)
Adjustments to reconcile net loss to net cash used in operating activities:    
Credit loss expense 643 1,570
Depreciation and amortization 6,291 6,250
Amortization of financing costs charged to interest expense 405 445
Amortization of right-of-use assets 632 549
Gain on debt extinguishment (5,350) 0
Stock-based compensation expense 8,694 10,985
Change in contingent consideration (60) (5,817)
Other non-cash (income) expense, net (2,620) 667
Change in operating assets and liabilities:    
Accounts receivable 7,536 13,323
Prepaid expenses and other assets (56) (3,450)
Accounts payable 551 125
Other accrued expenses 1,895 (7,634)
Partner Share liability (3,860) (13,291)
Consumer Incentive liability (8,245) (8,698)
Net cash used in operating activities (6,706) (17,617)
Investing activities    
Acquisition of property and equipment (119) (651)
Capitalized software development costs (3,984) (4,096)
Business divestiture 200 0
Net cash used in investing activities (3,903) (4,747)
Financing activities    
Settlement of contingent consideration 3,000 20,074
Proceeds from issuance of common stock 0 48,634
Debt issuance costs (34) (239)
Net cash (used in) provided by financing activities (3,034) 28,321
Effect of exchange rates on cash and cash equivalents 95 (21)
Net (decrease) increase in cash and cash equivalents (13,548) 5,936
Cash and cash equivalents — Beginning of period 65,594 91,830
Cash and cash equivalents — End of period 52,046 97,766
Supplemental disclosure of cash flow information:    
Cash paid for interest 253 1,862
Amounts accrued for property and equipment 171 98
Amounts accrued for capitalized software development costs 187 135
Issuance of common stock, net of issuance costs - Settlement Agreement (as defined below) $ 0 $ 27,451